Takeshima H - Search Results

1

Early-Stage Induction of SWI/SNF Mutations during Esophageal Squamous Cell Carcinogenesis.

Nakazato H, Takeshima H, Kishino T, Kubo E, Hattori N, Nakajima T, Yamashita S, Igaki H, Tachimori Y, Kuniyoshi Y, Ushijima T. Nakazato H, et al. Among authors: takeshima h. PLoS One. 2016 Jan 26;11(1):e0147372. doi: 10.1371/journal.pone.0147372. eCollection 2016. PLoS One. 2016. PMID: 26812616 Free PMC article.

2

The presence of RNA polymerase II, active or stalled, predicts epigenetic fate of promoter CpG islands.

Takeshima H, Yamashita S, Shimazu T, Niwa T, Ushijima T. Takeshima H, et al. Genome Res. 2009 Nov;19(11):1974-82. doi: 10.1101/gr.093310.109. Epub 2009 Aug 3. Genome Res. 2009. PMID: 19652013 Free PMC article.

3

Development of a novel output value for quantitative assessment in methylated DNA immunoprecipitation-CpG island microarray analysis.

Yamashita S, Hosoya K, Gyobu K, Takeshima H, Ushijima T. Yamashita S, et al. Among authors: takeshima h. DNA Res. 2009 Oct;16(5):275-86. doi: 10.1093/dnares/dsp017. Epub 2009 Sep 18. DNA Res. 2009. PMID: 19767598 Free PMC article.

4

Methylation destiny: Moira takes account of histones and RNA polymerase II.

Takeshima H, Ushijima T. Takeshima H, et al. Epigenetics. 2010 Feb 16;5(2):89-95. doi: 10.4161/epi.5.2.10774. Epub 2010 Feb 27. Epigenetics. 2010. PMID: 20160507 Free article.

5

Effects of genome architecture and epigenetic factors on susceptibility of promoter CpG islands to aberrant DNA methylation induction.

Takeshima H, Yamashita S, Shimazu T, Ushijima T. Takeshima H, et al. Genomics. 2011 Sep;98(3):182-8. doi: 10.1016/j.ygeno.2011.06.003. Epub 2011 Jun 12. Genomics. 2011. PMID: 21683780 Free article.

6

Early-stage formation of an epigenetic field defect in a mouse colitis model, and non-essential roles of T- and B-cells in DNA methylation induction.

Katsurano M, Niwa T, Yasui Y, Shigematsu Y, Yamashita S, Takeshima H, Lee MS, Kim YJ, Tanaka T, Ushijima T. Katsurano M, et al. Among authors: takeshima h. Oncogene. 2012 Jan 19;31(3):342-51. doi: 10.1038/onc.2011.241. Epub 2011 Jun 20. Oncogene. 2012. PMID: 21685942

7

Development of a novel approach, the epigenome-based outlier approach, to identify tumor-suppressor genes silenced by aberrant DNA methylation.

Kikuyama M, Takeshima H, Kinoshita T, Okochi-Takada E, Wakabayashi M, Akashi-Tanaka S, Ogawa T, Seto Y, Ushijima T. Kikuyama M, et al. Among authors: takeshima h. Cancer Lett. 2012 Sep 28;322(2):204-12. doi: 10.1016/j.canlet.2012.03.016. Epub 2012 Mar 17. Cancer Lett. 2012. PMID: 22433712

8

[Application of epigenetics to cancer diagnosis and therapy].

Ushijima T, Kikuyama M, Takeshima H. Ushijima T, et al. Among authors: takeshima h. Nihon Geka Gakkai Zasshi. 2012 Mar;113(2):191-6. Nihon Geka Gakkai Zasshi. 2012. PMID: 22582579 Review. Japanese.

9

Induction of aberrant trimethylation of histone H3 lysine 27 by inflammation in mouse colonic epithelial cells.

Takeshima H, Ikegami D, Wakabayashi M, Niwa T, Kim YJ, Ushijima T. Takeshima H, et al. Carcinogenesis. 2012 Dec;33(12):2384-90. doi: 10.1093/carcin/bgs294. Epub 2012 Sep 13. Carcinogenesis. 2012. PMID: 22976929

10

Comprehensive DNA methylation and extensive mutation analyses reveal an association between the CpG island methylator phenotype and oncogenic mutations in gastric cancers.

Kim JG, Takeshima H, Niwa T, Rehnberg E, Shigematsu Y, Yoda Y, Yamashita S, Kushima R, Maekita T, Ichinose M, Katai H, Park WS, Hong YS, Park CH, Ushijima T. Kim JG, et al. Among authors: takeshima h. Cancer Lett. 2013 Mar 1;330(1):33-40. doi: 10.1016/j.canlet.2012.11.022. Epub 2012 Nov 27. Cancer Lett. 2013. PMID: 23196062 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

682 results

Search Page

Filters